Similarly, other studies report that HER3 mRNA is increased in some ovarian cancer [60] patients and 16% of ovarian tumors show overexpression of HER3 protein compared to normal ovarian samples [61]. This evidence concerns the gene ERBB3 and ovarian carcinoma.